Various Radiopharmaceuticals
Closed Solicitation Posted
- Solicitation number
- W81K0025QA125
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Jbsa Ft Sam Houston, Texas 78234, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command is seeking to procure various radiopharmaceuticals to support the Nuclear Medicine Clinic at Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas through Solicitation W81K00-25-Q-A125. The procurement covers ten different radiopharmaceutical products including Ultratag RBC kits, Ioflupane, I-123 caps, MAG3 kits, MAA boxes, Sestamibi boxes, PYP vials, and Ultra Technekow for medical imaging and cancer treatment procedures. The contract will be structured as a Firm-Fixed-Price (FFP) Indefinite Delivery Indefinite Quantity (IDIQ) arrangement with orders placed on an as-needed basis. Award decisions will be made using the Lowest Price Technically Acceptable (LPTA) evaluation methodology. The quote submission deadline has been extended to September 12, 2025 at 1600 CST through Amendment 0003, which also removed certain cybersecurity requirements from the original solicitation.
This procurement is designated as a Women-Owned Small Business (WOSB) set-aside, limiting competition to qualifying firms in that category. No incumbent contractors are specifically identified in the solicitation documents. The contract includes a minimum guarantee of $100.00, with maximum quantities varying by item ranging from 10 Ultra Technekow units to 150 I-123 caps over the contract period, though Amendment 0002 revised the ordering period from five years to one year, significantly reducing the total quantities. The contract performance period will run from October 1, 2025 through September 30, 2026, with all deliveries required to be completed by October 31, 2026. All radiopharmaceuticals must be delivered directly to the Nuclear Medicine Clinic at BAMC, which operates 24 hours a day, seven days a week, with special delivery requirements for Ioflupane products that must arrive within two days of ordering.
Notice text
4 versions
Update #4 · Latest ·
***AMENDMENT 0003*** THE PURPOSE OF THIS AMENDMENT IS TO REMOVE DFARS CLAUSE 252.204-7012 FROM THE SOLICITATION. THE QUOTE DUE DATE IS HEREBY EXTENDED TO 12 SEP 2025 AT 1600 CST.
***AMENDMENT 0002*** THE PURPOSE OF THIS AMENDMENT IS TO REVISE THE REQUIREMENT FROM A FIVE-YEAR ORDERING PERIOD TO A ONE-YEAR ORDERING PERIOD. THE QUOTE DUE DATE IS HEREBY EXTENDED TO 11 SEP 2025 AT 1600 CST.
***AMENDMENT 0001*** THE PURPOSE OF THIS AMENDMENT IS TO: (1) INCORPORATE CLIN 0011 "POST AWARD CONFERENCE" WHICH WILL SATISFY THE $100.00 MINIMUM GUARANTEE ESTABLISHED FOR THE RESULTANT IDIQ CONTRACT AND (2) UPDATE THE STATEMENT OF WORK TO SPECIFY THE DELIVERY TIMEFRAME FOR IOFLUPANE.
Solicitation W81K00-25-Q-A125 is hereby issued for various radiopharmaceuticals in support of Brooke Army Medical Center (BAMC), JBSA Fort Sam Houston, TX. The resultant contract will be a Firm-Fixed-Price (FFP) Indefinite Delivery Indefinite Quantity (IDIQ) contract with a five-year ordering period. Period of Performance: 01 OCT 2025 through 30 SEP 2030. Refer to attached Solicitation W81K00-25-Q-A125 and Statement of Work.
Solicitation PSC/NAICS 6505 (Drugs and Pharmaceutical Products) / 325412 (Phrmaceutical Preparation Manufacturing)
Update #3 ·
***AMENDMENT 0002*** THE PURPOSE OF THIS AMENDMENT IS TO REVISE THE REQUIREMENT FROM A FIVE-YEAR ORDERING PERIOD TO A ONE-YEAR ORDERING PERIOD. THE QUOTE DUE DATE IS HEREBY EXTENDED TO 11 SEP 2025 AT 1600 CST.
***AMENDMENT 0001*** THE PURPOSE OF THIS AMENDMENT IS TO: (1) INCORPORATE CLIN 0011 "POST AWARD CONFERENCE" WHICH WILL SATISFY THE $100.00 MINIMUM GUARANTEE ESTABLISHED FOR THE RESULTANT IDIQ CONTRACT AND (2) UPDATE THE STATEMENT OF WORK TO SPECIFY THE DELIVERY TIMEFRAME FOR IOFLUPANE.
Solicitation W81K00-25-Q-A125 is hereby issued for various radiopharmaceuticals in support of Brooke Army Medical Center (BAMC), JBSA Fort Sam Houston, TX. The resultant contract will be a Firm-Fixed-Price (FFP) Indefinite Delivery Indefinite Quantity (IDIQ) contract with a five-year ordering period. Period of Performance: 01 OCT 2025 through 30 SEP 2030. Refer to attached Solicitation W81K00-25-Q-A125 and Statement of Work.
Solicitation PSC/NAICS 6505 (Drugs and Pharmaceutical Products) / 325412 (Phrmaceutical Preparation Manufacturing)
Update #2 ·
***AMENDMENT 0001*** THE PURPOSE OF THIS AMENDMENT IS TO: (1) INCORPORATE CLIN 0011 "POST AWARD CONFERENCE" WHICH WILL SATISFY THE $100.00 MINIMUM GUARANTEE ESTABLISHED FOR THE RESULTANT IDIQ CONTRACT AND (2) UPDATE THE STATEMENT OF WORK TO SPECIFY THE DELIVERY TIMEFRAME FOR IOFLUPANE.
Solicitation W81K00-25-Q-A125 is hereby issued for various radiopharmaceuticals in support of Brooke Army Medical Center (BAMC), JBSA Fort Sam Houston, TX. The resultant contract will be a Firm-Fixed-Price (FFP) Indefinite Delivery Indefinite Quantity (IDIQ) contract with a five-year ordering period. Period of Performance: 01 OCT 2025 through 30 SEP 2030. Refer to attached Solicitation W81K00-25-Q-A125 and Statement of Work.
Solicitation PSC/NAICS 6505 (Drugs and Pharmaceutical Products) / 325412 (Phrmaceutical Preparation Manufacturing)
Update #1 ·
Solicitation W81K00-25-Q-A125 is hereby issued for various radiopharmaceuticals in support of Brooke Army Medical Center (BAMC), JBSA Fort Sam Houston, TX. The resultant contract will be a Firm-Fixed-Price (FFP) Indefinite Delivery Indefinite Quantity (IDIQ) contract with a five-year ordering period. Period of Performance: 01 OCT 2025 through 30 SEP 2030. Refer to attached Solicitation W81K00-25-Q-A125 and Statement of Work.
Solicitation PSC/NAICS 6505 (Drugs and Pharmaceutical Products) / 325412 (Phrmaceutical Preparation Manufacturing)
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Various Radiopharmaceuticals | Pre-Solicitation | |
| Various Radiopharmaceuticals | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | Veterans Integrated Service Network 10 | No set-aside | |
| H365--460-27-1-132-0001 | SPE 49273 | VISN 4 Radiation Safety Officer (RSO) | NCO 4 Services 3 (VA-27-00003148) | Veterans Integrated Service Network 4 | Service-Disabled Veteran-Owned Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity